The transcription factor, hypoxia-inducible factor (HIF)-1, is the master regulator for tumor adaptation to hypoxia generated by rapid cell growth and chaotic and fragile blood vessel networks [1–3]. This evidence concerns the gene SETD2 and neoplasm.